Northeast Financial Consultants Inc Cognition Therapeutics Inc Put Options Transaction History
Northeast Financial Consultants Inc
- $2.22 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CGTX
# of Institutions
58Shares Held
13.1MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$1.98 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$727,7740.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$408,9250.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$200,7680.01% of portfolio
-
Voss Capital, LLC Houston, TX450KShares$148,5000.02% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $7.49M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...